Medikamentöse Senkung des LDL-Cholesterins

Jens Barthelmes; Isabella Sudano

doi:10.1024/1661-8157/a002759

Medikamentöse Senkung des LDL-Cholesterins

Praxis (Bern 1994). 2017 Aug;106(17):933-940. doi: 10.1024/1661-8157/a002759.

[Article in German]

Authors

Jens Barthelmes¹, Isabella Sudano²

Affiliations

¹ 1 Kardiologie, Universitäres Herzzentrum, Universitätsspital Zürich.
² 2 Universität Zürich.

PMID: 28830329
DOI: 10.1024/1661-8157/a002759

No abstract available

Keywords: Cholesterin; Cholesterol; Cholestérol; Ezetimib; PCSK9 inhibitors; PCSK9-Hemmer; Statin; cardiovascular risk; ezetimibe; inhibiteur de la PCSK9; kardiovaskuläres Risiko; statin; statine; ézétimibe.

Publication types

Review

MeSH terms

Cholesterol, LDL / blood*
Ezetimibe / therapeutic use
Fibric Acids / therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Hypercholesterolemia / blood*
Hypercholesterolemia / drug therapy*
PCSK9 Inhibitors
Secondary Prevention

Substances

Cholesterol, LDL
Fibric Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
PCSK9 Inhibitors
PCSK9 protein, human
Ezetimibe